SCHEMBL1615053

SCHEMBL1615053

CCCCC(C)C(C)CCC(C)C

nearest known ligand 0.39

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 2/20 0.39
OPRM1 P35372 1/20 0.38
LMNA P02545 2/20 0.35
ALDH1A1 P00352 3/20 0.35
TDP1 Q9NUW8 1/20 0.35
TSHR P16473 4/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CYP3A4 P08684 1/20 0.33
FDPS P14324 1/20 0.33
CA2 P00918 2/20 0.32
MAPK1 P28482 1/20 0.32
THRB P10828 1/20 0.32
CA1 P00915 1/20 0.31
TRPM8 Q7Z2W7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3185161 0.87 DNM1 (0.47) DNM1OPRM1LMNAALDH1A1TDP1
SCHEMBL22345156 0.87 DNM1 (0.47) DNM1OPRM1LMNAALDH1A1TDP1
SCHEMBL17998774 0.85 DNM1 (0.33) DNM1OPRM1ALDH1A1TDP1
SCHEMBL6531560 0.81 DNM1 (0.43) DNM1OPRM1LMNAALDH1A1TDP1
SCHEMBL21989961 0.81 METAP1 (0.37) LMNATSHR
SCHEMBL27568406 0.81 OPRM1 (0.55) DNM1OPRM1LMNATSHRFDPS
SCHEMBL38853 0.81
SCHEMBL10013141 0.81 LMNA (0.50) DNM1OPRM1LMNAALDH1A1TDP1
SCHEMBL15238776 0.80 ALDH1A1 (0.39) DNM1OPRM1LMNAALDH1A1TDP1
SCHEMBL599090 0.79 ALDH1A1 (0.42) DNM1OPRM1LMNAALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3846691-A2 SYSTEM FOR DETECTION OF VOLATILE ORGANIC COMPOUNDS (VOC) IN EXHALED BREATH FOR HEALTH MONITORING Kozhnosys Private Limited (IN) 2021-07-14 EP claimed
US-20210186367-A1 SYSTEM FOR DETECTION OF VOLATILE ORGANIC COMPOUNDS (VOC) IN EXHALED BREATH FOR HEALTH MONITORING KOZHNOSYS PRIVATE LIMITED (IN) 2021-06-24 US claimed
EP-2406370-A1 ALGAE BIOMASS FRACTIONATION SRS Energy (US) 2012-01-18 EP claimed
WO-2010104922-A1 ALGAE BIOMASS FRACTIONATION SRS ENERGY (US) 2010-09-16 WO claimed
US-20100233761-A1 ALGAE BIOMASS FRACTIONATION Valicor, Inc. 2010-09-16 US claimed
EP-4747303-A2 DISTILLATION OF PLASTIC WASTE TO FORM WATERPROOFING PRODUCTS Fairway Cost Consultancy Limited (GB) 2026-05-27 EP disclosed
US-12429483-B2 System and method for determining onset and disease progression RESPIRATION SCAN LTD (IL) 2025-09-30 US disclosed
US-20250197341-A1 METHOD FOR INHIBITING CRYSTALLISATION BIOSYNTHIS (FR) 2025-06-19 US disclosed
WO-2025017082-A2 DISTILLATION OF PLASTIC WASTE TO FORM WATERPROOFING PRODUCTS Fairway Cost Consultancy Limited (GB) 2025-01-23 WO disclosed
CN-118844594-A Sweetener and flavor compositions, methods of making and methods of using the same 伊比西(北京)植物药物技术有限公司 2024-10-29 CN disclosed
EP-4164481-B1 A DEVICE FOR MEASURING VOLATILE MARKERS IN BREATH NANOSE MEDICAL LTD (IL) 2024-10-16 EP disclosed
US-12048316-B2 Sweetener and flavor compositions, methods of making and methods of use thereof EPC NATURAL PRODUCTS CO., LTD. (CN) 2024-07-30 US disclosed
WO-2019217310-A1 SWEETENER AND FLAVOR COMPOSITIONS, METHODS OF MAKING AND METHODS OF USE THEREOF EPC NATURAL PRODUCTS CO., LTD. (CN) 2019-11-14 WO disclosed
WO-2019217269-A1 A TASTEFUL NATURAL SWEETENER AND FLAVOR EPC NATURAL PRODUCTS CO., LTD. (CN) 2019-11-14 WO disclosed
US-9296985-B2 Algae biomass fractionation Valicor, Inc. (US) 2016-03-29 US disclosed
WO-2012078852-A2 ALGAE BIOMASS FRACTIONATION SRS ENERGY (US) 2012-06-14 WO disclosed
EP-2406370-A1 ALGAE BIOMASS FRACTIONATION SRS Energy (US) 2012-01-18 EP disclosed
US-20110086386-A1 ALGAE BIOMASS FRACTIONATION TRUCENT, INC. 2011-04-14 US disclosed
WO-2010104922-A1 ALGAE BIOMASS FRACTIONATION SRS ENERGY (US) 2010-09-16 WO disclosed
US-20100233761-A1 ALGAE BIOMASS FRACTIONATION Valicor, Inc. 2010-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250197341-A1 METHOD FOR INHIBITING CRYSTALLISATION FASN, SCD5, NFKB2 DNM1 1631/4885OPRM1 4200/4885LMNA 149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.